Specific bardoxolone methyl crystalline forms lower pro-inflammatory cytokine concentrations, preventing acute kidney injury and respiratory distress syndrome.
Modified naphthalene derivatives overcome toxicity and permeability limits, enabling reliable in vivo Alzheimer's diagnosis.
A novel compound enables solution processing of organic light emitting device layers to improve efficiency and reduce driving voltage.
Deuterated Formula I compounds improve color saturation and efficiency, resolving industry standards for full-color displays.
Controlled crystallization transforms unstable TY706 into a stable crystal form with consistent appearance, resolving batch-to-batch variability.
Non-adjacent 13C labeling eliminates spin couplings to resolve structural analysis bottlenecks in proteins exceeding 80 kDa.
Isomerizing hydrohalofluoroolefins in gas phase while maintaining catalyst performance by limiting feedstock moisture concentration to 100 ppm or lower.
Switching to ether solvents during resolution of the citalopram intermediate eliminates filtration difficulties and repurification steps.
Developing multiple solid state forms including polymorphs and co-crystals improves stability and bioavailability while managing manufacturing complexity.